DNA methylation reprogramming in cancer: Does it act by re-configuring the binding landscape of Polycomb repressive complexes?

BioEssays

Volumn 36, Issue 2, 2014, Pages 134-140

  Reddington, James P ^a,b   Sproul, Duncan ^a   Meehan, Richard R ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b EUROPEAN MOLECULAR BIOLOGY LABORATORY   (Germany)

Author keywords

Cancer epigenetics; DNA methylation; Epigenomics; H3K27me3; Polycomb; Reprogramming

Indexed keywords

BMI1 PROTEIN; DNA METHYLTRANSFERASE 1; DNA METHYLTRANSFERASE 3A; DNA METHYLTRANSFERASE 3B; HISTONE H3; METHYL CPG BINDING PROTEIN; POLYCOMB GROUP PROTEIN; POLYCOMB REPRESSIVE COMPLEX 2;

ARTICLE; BINDING SITE; CANCER GROWTH; CARCINOGENESIS; CELL CYCLE REGULATION; CELL FATE; CHROMATIN STRUCTURE; DEVELOPMENTAL GENETICS; DNA METHYLATION; DNA RESPONSIVE ELEMENT; DNA SEQUENCE; GENE CONTROL; GENE REPRESSION; GENOME IMPRINTING; HUMAN; NEOPLASM; NONHUMAN; NUCLEAR REPROGRAMMING; PROMOTER REGION; PROTEIN BINDING; RETROPOSON; TRANSCRIPTION INITIATION; TRANSGENIC ANIMAL; TUMOR SUPPRESSOR GENE; ANIMAL; GENETIC EPIGENESIS; GENETICS; METABOLISM; PHYSIOLOGY;

ANIMALS; DNA METHYLATION; EPIGENESIS, GENETIC; HUMANS; NEOPLASMS; POLYCOMB-GROUP PROTEINS;

EID: 84892446057     PISSN: 02659247     EISSN: 15211878     Source Type: Journal    
DOI: 10.1002/bies.201300130     Document Type: Article

References (50)

1. Reddington JP, Pennings S, Meehan RR. 2013. Non-canonical functions of the DNA methylome in gene regulation. Biochem J 451: 13-23.
2. Schlesinger Y, Straussman R, Keshet I, Farkash S, et al. 2007. Polycomb-mediated methylation on Lys27 of histone H3 pre-marks genes for de novo methylation in cancer. Nat Genet 39: 232-6.
3. Hon GC, Hawkins RD, Caballero OL, Lo C, et al. 2012. Global DNA hypomethylation coupled to repressive chromatin domain formation and gene silencing in breast cancer. Genome Res 22: 246-58.
4. Cedar H, Bergman Y. 2012. Programming of DNA methylation patterns. Annu Rev Biochem 81: 97-117.
5. Deaton AM, Bird A. 2011. CpG islands and the regulation of transcription. Genes Dev 25: 1010-22.
6. Branco MR, Ficz G, Reik W. 2012. Uncovering the role of 5-hydroxymethylcytosine in the epigenome. Nat Rev Genet 13: 7-13.
7. Klose RJ, Bird AP. 2006. Genomic DNA methylation: the mark and its mediators. Trends Biochem Sci 31: 89-97.
8. Feinberg AP, Tycko B. 2004. The history of cancer epigenetics. Nat Rev Cancer 4: 143-53.
9. Ohm JE, McGarvey KM, Yu X, Cheng L, et al. 2007. A stem cell-like chromatin pattern may predispose tumor suppressor genes to DNA hypermethylation and heritable silencing. Nat Genet 39: 237-42.
10. Widschwendter M, Fiegl H, Egle D, Mueller-Holzner E, et al. 2007. Epigenetic stem cell signature in cancer. Nat Genet 39: 157-8.
11. Sproul D, Meehan RR. 2013. Genomic insights into cancer-associated aberrant CpG island hypermethylation. Brief Funct Genomics 12: 174-90.
12. Sproul D, Nestor C, Culley J, Dickson JH, et al. 2011. Transcriptionally repressed genes become aberrantly methylated and distinguish tumors of different lineages in breast cancer. Proc Natl Acad Sci USA 108: 4364-9.
13. Keshet I, Schlesinger Y, Farkash S, Rand E, et al. 2006. Evidence for an instructive mechanism of de novo methylation in cancer cells. Nat Genet 38: 149-53.
14. Timp W, Feinberg AP. 2013. Cancer as a dysregulated epigenome allowing cellular growth advantage at the expense of the host. Nat Rev Cancer 13: 497-510.
15. Hansen KD, Timp W, Bravo HC, Sabunciyan S, et al. 2011. Increased methylation variation in epigenetic domains across cancer types. Nat Genet 43: 768-75.
16. Berman BP, Weisenberger DJ, Aman JF, Hinoue T, et al. 2012. Regions of focal DNA hypermethylation and long-range hypomethylation in colorectal cancer coincide with nuclear lamina-associated domains. Nat Genet 44: 40-6.
17. Gaudet F, Hodgson JG, Eden A, Jackson-Grusby L, et al. 2003. Induction of tumors in mice by genomic hypomethylation. Science 300: 489-92.
18. Yamada Y, Jackson-Grusby L, Linhart H, Meissner A, et al. 2005. Opposing effects of DNA hypomethylation on intestinal and liver carcinogenesis. Proc Natl Acad Sci USA 102: 13580-5.
19. Hernandez R, Frady A, Zhang XY, Varela M, et al. 1997. Preferential induction of chromosome 1 multibranched figures and whole-arm deletions in a human pro-B cell line treated with 5-azacytidine or 5-azadeoxycytidine. Cytogenet Cell Genet 76: 196-201.
20. Xu GL, Bestor TH, Bourc'his D, Hsieh CL, et al. 1999. Chromosome instability and immunodeficiency syndrome caused by mutations in a DNA methyltransferase gene. Nature 402: 187-91.
21. Rodic N, Burns KH. 2013. Long interspersed element-1 (LINE-1): passenger or driver in human neoplasms? PLoS Genet 9: e1003402.
22. Lee E, Iskow R, Yang L, Gokcumen O, et al. 2012. Landscape of somatic retrotransposition in human cancers. Science 337: 967-71.
23. Shukla R, Upton KR, Munoz-Lopez M, Gerhardt DJ, et al. 2013. Endogenous retrotransposition activates oncogenic pathways in hepatocellular carcinoma. Cell 153: 101-11.
24. Wolff EM, Byun HM, Han HF, Sharma S, et al. 2010. Hypomethylation of a LINE-1 promoter activates an alternate transcript of the MET oncogene in bladders with cancer. PLoS Genet 6: e1000917.
25. Cruickshanks HA, Vafadar-Isfahani N, Dunican DS, Lee A, et al. 2013. Expression of a large LINE-1-driven antisense RNA is linked to epigenetic silencing of the metastasis suppressor gene TFPI-2 in cancer. Nucleic Acids Res 41: 6857-9.
26. Bartke T, Vermeulen M, Xhemalce B, Robson SC, et al. 2010. Nucleosome-interacting proteins regulated by DNA and histone methylation. Cell 143: 470-84.
27. Meissner A, Mikkelsen TS, Gu H, Wernig M, et al. 2008. Genome-scale DNA methylation maps of pluripotent and differentiated cells. Nature 454: 766-70.
28. Lister R, Pelizzola M, Dowen RH, Hawkins RD, et al. 2009. Human DNA methylomes at base resolution show widespread epigenomic differences. Nature 462: 315-22.
29. Murphy PJ, Cipriany BR, Wallin CB, Ju CY, et al. 2013. Single-molecule analysis of combinatorial epigenomic states in normal and tumor cells. Proc Natl Acad Sci USA 110: 7772-7.
30. Hawkins RD, Hon GC, Lee LK, Ngo Q, et al. 2010. Distinct epigenomic landscapes of pluripotent and lineage-committed human cells. Cell Stem Cell 6: 479-91.
31. Brinkman AB, Gu H, Bartels SJ, Zhang Y, et al. 2012. Sequential ChIP-bisulfite sequencing enables direct genome-scale investigation of chromatin and DNA methylation cross-talk. Genome Res 22: 1128-38.
32. Kondo Y, Shen L, Cheng AS, Ahmed S, et al. 2008. Gene silencing in cancer by histone H3 lysine 27 trimethylation independent of promoter DNA methylation. Nat Genet 40: 741-50.
33. Lindroth AM, Park YJ, McLean CM, Dokshin GA, et al. 2008. Antagonism between DNA and H3K27 methylation at the imprinted Rasgrf1 locus. PLoS Genet 4: e1000145.
34. Wu H, Coskun V, Tao J, Xie W, et al. 2010. Dnmt3a-dependent nonpromoter DNA methylation facilitates transcription of neurogenic genes. Science 329: 444-8.
35. Reddington JP, Perricone SM, Nestor CE, Reichmann J, et al. 2013. Redistribution of H3K27me3 upon DNA hypomethylation results in de-repression of Polycomb target genes. Genome Biol 14: R25.
36. Lynch MD, Smith AJ, De Gobbi M, Flenley M, et al. 2012. An interspecies analysis reveals a key role for unmethylated CpG dinucleotides in vertebrate Polycomb complex recruitment. EMBO J 31: 317-29.
37. Deleris A, Stroud H, Bernatavichute Y, Johnson E, et al. 2012. Loss of the DNA methyltransferase MET1 Induces H3K9 hypermethylation at PcG target genes and redistribution of H3K27 trimethylation to transposons in Arabidopsis thaliana. PLoS Genet 8: e1003062.
38. Williams K, Christensen J, Pedersen MT, Johansen JV, et al. 2011. TET1 and hydroxymethylcytosine in transcription and DNA methylation fidelity. Nature 473: 343-8.
39. Hagarman JA, Motley MP, Kristjansdottir K, Soloway PD. 2013. Coordinate regulation of DNA methylation and H3K27me3 in mouse embryonic stem cells. PLoS One 8: e53880.
40. Simon JA, Kingston RE. 2013. Occupying chromatin: Polycomb mechanisms for getting to genomic targets, stopping transcriptional traffic, and staying put. Mol Cell 49: 808-24.
41. Farcas AM, Blackledge NP, Sudbery I, Long HK, et al. 2012. KDM2B links the Polycomb repressive complex 1 (PRC1) to recognition of CpG islands. eLife 1: e00205.
42. Cheng AS, Lau SS, Chen Y, Kondo Y, et al. 2011. EZH2-mediated concordant repression of Wnt antagonists promotes beta-catenin-dependent hepatocarcinogenesis. Cancer Res 71: 4028-39.
43. Gal-Yam EN, Egger G, Iniguez L, Holster H, et al. 2008. Frequent switching of Polycomb repressive marks and DNA hypermethylation in the PC3 prostate cancer cell line. Proc Natl Acad Sci USA 105: 12979-84.
44. Margueron R, Justin N, Ohno K, Sharpe ML, et al. 2009. Role of the polycomb protein EED in the propagation of repressive histone marks. Nature 461: 762-7.
45. Rheinbay E, Suva ML, Gillespie SM, Wakimoto H, et al. 2013. An aberrant transcription factor network essential for Wnt signaling and stem cell maintenance in glioblastoma. Cell Rep 3: 1567-79.
46. Bert SA, Robinson MD, Strbenac D, Statham AL, et al. 2013. Regional activation of the cancer genome by long-range epigenetic remodeling. Cancer Cell 23: 9-22.
47. Heyn H, Li N, Ferreira HJ, Moran S, et al. 2012. Distinct DNA methylomes of newborns and centenarians. Proc Natl Acad Sci USA 109: 10522-7.
48. Schroeder DI, Blair JD, Lott P, Yu HO, et al. 2013. The human placenta methylome. Proc Natl Acad Sci USA 110: 6037-42.
49. Kulis M, Heath S, Bibikova M, Queiros AC, et al. 2012. Epigenomic analysis detects widespread gene-body DNA hypomethylation in chronic lymphocytic leukemia. Nat Genet 44: 1236-42.
50. Issa JP. 2011. Epigenetic variation and cellular Darwinism. Nat Genet 43: 724-6.